Target intelligence / Profile preview

COP9 signalosome complex subunit 5 (CSN5)

Target
CSN5
Molecular classification
Enzyme, Metalloprotease, Isopeptidase, COP9 signalosome subunit
01

Overview

COP9 signalosome complex subunit 5 (CSN5), also known as JAB1, is a zinc-dependent metalloprotease and isopeptidase that forms the catalytic core of the COP9 signalosome (CSN), an evolutionarily conserved multi-protein complex involved in the regulation of ubiquitin-proteasome-mediated protein degradation via deneddylation of cullin-RING ubiquitin ligases[1][3][4][5][8]. CSN5 contains a signature Jab1/MPN/Mov34 (JAMM) motif that chelates metal ions and confers catalytic activity[1][7]. CSN5 plays a critical role in cell cycle progression, cell survival, and transcription regulation and is considered an oncogene due to its frequent overexpression in human cancers and association with poor prognosis[2]. In addition to its function within the CSN, CSN5 may also operate as a monomer or in smaller complexes and interacts with several key cell cycle and signaling proteins, including CDK2 and c-Jun[2]. Its biological and biochemical importance, essential roles in development, and implication as a cancer driver make it a significant therapeutic target, though safety concerns exist due to its essential cellular functions[2][4][7].

Other names
JAB1COPS5Jab1/CSN5c-Jun activation domain-binding protein-1Jab1CSN subunit 5
02

Mechanism of action

Inhibition of CSN5’s isopeptidase/deneddylase catalytic activity (primarily at the JAMM motif)[7]. Inhibition of protein deneddylation, leading to impaired function of cullin-RING ubiquitin ligases and altered protein degradation[7].

03

Biological functions

Protein deneddylation (removal of Nedd8 from target proteins)Regulation of cell proliferationRegulation of cell cycle and signal transductionRegulation of transcription factor specificityProtein complex assemblyProtein degradation (via modulation of ubiquitin-proteasome system)Control of intracellular distribution of signaling molecules
04

Disease associations

CancerCell proliferation disordersDevelopmental defects
05

Safety considerations

Essential for embryonic development—complete inhibition likely toxic[2].Broad roles in multi-protein assemblies imply that systemic inhibition may impact cell cycle and survival pathways in non-cancerous cells[2].
06

Interacting drugs

None explicitly approved or in clinical use are listed, but JAMM/MPN motif metalloprotease inhibitors are in research; proteasome inhibitors like bortezomib are conceptually relevant[7].
07

Biomarkers

Overexpression of CSN5/JAB1 in tumors (prognostic in cancer)[2].CSN5 expression as a marker of malignant transformation or poor prognosis in multiple cancers[2].

Beyond the preview

Go deeper on COP9 signalosome complex subunit 5 (CSN5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on COP9 signalosome complex subunit 5 (CSN5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call